Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -22.556% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COc1ccc(CCNC(=O)COC(=O)c2ccc([N+](=O)[O-])o2)cc1
b. Nn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccncc1
Answer: b. Nn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccncc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccncc1
Nn1c(SCC(=O)Nc2ccc3c(c2)OCCO3)nnc1-c1ccncc1
2-[(4-amino-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamide